Skip to content
10-Q

Quarterly Report

HEALTHEQUITY, INC. HQY

0001428336-25-000036

← back to feed
Filed
Dec 3, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2026 · Nov 21, 2025 85.44M sh
Shares Diluted Q3 2026 · Oct 31, 2025 86.97M sh
Shares Diluted Q3 2026 · Oct 31, 2025 87.8M sh
Shares Diluted Q3 2026 · Oct 31, 2024 88.63M sh
Shares Diluted Q3 2026 · Oct 31, 2024 88.7M sh
Stock Repurchased Q3 2026 · Oct 31, 2025 $218.23M
Stock Repurchased Q3 2026 · Oct 31, 2024 $58.51M
Capex Q3 2026 · Oct 31, 2025 $1.64M
Capex Q3 2026 · Oct 31, 2024 $1.76M
Operating Cash Flow Q3 2026 · Oct 31, 2025 $339.18M
Operating Cash Flow Q3 2026 · Oct 31, 2024 $264.11M
Long Term Debt Q3 2026 · Oct 31, 2025 $982.11M
Long Term Debt Q3 2026 · Jan 31, 2025 $1.06B
Short Term Debt Q3 2026 · Oct 31, 2025 $0
Short Term Debt Q3 2026 · Jan 31, 2025 $0
Cash And Equivalents Q3 2026 · Oct 31, 2025 $309.26M
Cash And Equivalents Q3 2026 · Jan 31, 2025 $295.95M
Stockholders Equity Q3 2026 · Oct 31, 2025 $2.13B
Stockholders Equity Q3 2026 · Jul 31, 2025 $2.15B
Stockholders Equity Q3 2026 · Jan 31, 2025 $2.11B
Stockholders Equity Q3 2026 · Oct 31, 2024 $2.12B
Stockholders Equity Q3 2026 · Jul 31, 2024 $2.16B
Stockholders Equity Q3 2026 · Jan 31, 2024 $2.04B
Current Liabilities Q3 2026 · Oct 31, 2025 $120.63M
Current Liabilities Q3 2026 · Jan 31, 2025 $156.32M
Total Liabilities Q3 2026 · Oct 31, 2025 $1.26B
Total Liabilities Q3 2026 · Jan 31, 2025 $1.33B
Current Assets Q3 2026 · Oct 31, 2025 $498.71M
Current Assets Q3 2026 · Jan 31, 2025 $477.75M
Total Assets Q3 2026 · Oct 31, 2025 $3.4B
Total Assets Q3 2026 · Jan 31, 2025 $3.45B
Eps Diluted Q3 2026 · Oct 31, 2025 $0.59
Eps Diluted Q3 2026 · Oct 31, 2025 $1.88
Eps Diluted Q3 2026 · Oct 31, 2024 $0.06
Eps Diluted Q3 2026 · Oct 31, 2024 $0.79
Eps Basic Q3 2026 · Oct 31, 2025 $0.60
Eps Basic Q3 2026 · Oct 31, 2025 $1.92
Eps Basic Q3 2026 · Oct 31, 2024 $0.07
Eps Basic Q3 2026 · Oct 31, 2024 $0.81
Sga Expense Q3 2026 · Oct 31, 2025 $30.88M
Sga Expense Q3 2026 · Oct 31, 2025 $86.41M
Sga Expense Q3 2026 · Oct 31, 2024 $31.79M
Sga Expense Q3 2026 · Oct 31, 2024 $102.29M
Rd Expense Q3 2026 · Oct 31, 2025 $65.92M
Rd Expense Q3 2026 · Oct 31, 2025 $192.16M
Rd Expense Q3 2026 · Oct 31, 2024 $60.19M
Rd Expense Q3 2026 · Oct 31, 2024 $174.86M
Net Income Q3 2026 · Oct 31, 2025 $51.69M
Net Income Q3 2026 · Oct 31, 2025 $165.46M
Net Income Q3 2026 · Oct 31, 2024 $5.7M
Net Income Q3 2026 · Oct 31, 2024 $70.34M
Operating Income Q3 2026 · Oct 31, 2025 $78.7M
Operating Income Q3 2026 · Oct 31, 2025 $251.39M
Operating Income Q3 2026 · Oct 31, 2024 $19.63M
Operating Income Q3 2026 · Oct 31, 2024 $120.18M
Gross Profit Q3 2026 · Oct 31, 2025 $228.06M
Gross Profit Q3 2026 · Oct 31, 2025 $684.97M
Gross Profit Q3 2026 · Oct 31, 2024 $197.03M
Gross Profit Q3 2026 · Oct 31, 2024 $588.22M
Cost Of Revenue Q3 2026 · Oct 31, 2025 $94.1M
Cost Of Revenue Q3 2026 · Oct 31, 2025 $293.87M
Cost Of Revenue Q3 2026 · Oct 31, 2024 $103.41M
Cost Of Revenue Q3 2026 · Oct 31, 2024 $299.74M
Revenue Q3 2026 · Oct 31, 2025 $322.16M
Revenue Q3 2026 · Oct 31, 2025 $978.84M
Revenue Q3 2026 · Oct 31, 2024 $300.43M
Revenue Q3 2026 · Oct 31, 2024 $887.96M